|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement From the American Heart Association显示文摘 | Larry M. Baddour Andrew E. Epstein Christopher C. Erickson Bradley P. Knight Matthew E. Levison Peter B. Lockhart Frederick A. Masoudi Eric J. Okum Walter R. Wilson Lee B. Beerman Ann F. Bolger N A. Mark Estes Michael Gewitz Jane W. Newburger Eleanor B. S | 2010 | Circulation2010，，3： | 4 |
| 2 | Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack显示文摘 | S Claiborne Johnston Peter M Rothwell Mai N Nguyen-Huynh Matthew F Giles Jacob S Elkins Allan L Bernstein Stephen Sidney | 2007 | 2007 (9558)2007，，9558： | 3 |
| 3 | Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders显示文摘 | E Joanna Baxter Linda M Scott Peter J Campbell Clare East Nasios Fourouclas Soheila Swanton George S Vassiliou Anthony J Bench Elaine M Boyd Natasha Curtin Mike A Scott Wendy N Erber Anthony R Green | 2005 | The Lancet . 2005 (9464)2005，，： | 2 |
| 4 | 重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls. | Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD | 2018 | 中华神经外科疾病研究杂志2018，17，4： | 2 |
| 5 | Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack显示文摘 | S Claiborne Johnston Peter M Rothwell Mai N Nguyen-Huynh Matthew F Giles Jacob S Elkins Allan L Bernstein Stephen Sidney | 2007 | The Lancet . 2007 (9558)2007，，9558： | 2 |
| 6 | Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity显示文摘浆液睾丸激素不与雄激素织物活动相关,并且优化工具在男性评估如此的活动是批评的。bulbocavernosus 肌肉(BCM ) 的超声测量被用来在雄激素受体(AR ) 和 BCM 尺寸估计在 CAG 重复(CAGn ) 的数字之间的关系;在 CAGn 超龄的数字的变化也被评估。BCM 的 Transperineal 超声测量也被执行。AR CAGn 被高效液体层析,和早上荷尔蒙决定层次用免疫分析被决定。48 个人让 CAG 重复分析。25 是 < 30 岁,平均数 23.7 年(s.d = 3.24 ) 并且 23 是 > 45 岁,平均数 53 年(s.d = 5.58 ) 。中部的 CAGn 是 21 (13-29 ) 。当 CAGn 的数字是 < 时, BCM 区域更大; 18 作为与 CAGn > 的数字相比; 24 (P = 0.04 ) 。在 CAGn 和 BCM 区域 R 2= 的数字之间有线性关联 16%(P = 0.01 ) 。在 45 到 65-years-old 组,强壮得多的否定关联(R 2=29% , P = 0.01 ) 被注意。在 19,到 29-years-old 组,,没有如此的关联被发现(R 2=4% , P = 0.36 ) 。在老人, CAGn 的数字与年龄增加了(R 2=32% , P = 0.01 ) 。在 AR 的 CAGn 的数字与 BCM 的区域相关。对 BCM 的超声评价是一个有效代理人评估雄激素的结束器官活动。CAGn 的数字可以与年龄增加。 | Ali A Dabaja Matthew S Wosnitzer Anna Mielnik Alexander Bolyakov Peter N Schlegel Darius A Paduch | 2014 | Asian Journal of Andrology2014，16，4： | 2 |
| 7 | Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack显示文摘 | S Claiborne Johnston Peter M Rothwell Mai N Nguyen-Huynh Matthew F Giles Jacob S Elkins Allan L Bernstein Stephen Sidney | 2007 | The Lancet2007，，9558： | 2 |
| 8 | Update of endoscopy in liver disease:More than just treating varices显示文摘The management of complications in liver disease is often complex and challenging.Endoscopy has undergone a period of rapid expansion with numerous novel and specialized endoscopic modalities that are of increasing value in the investigation and management of the patient with liver disease.In this review,relevant literature search and expert opinions have been used to provide a brief overview and update of the current endoscopic management of patients with liver disease and portal hypertension.The main areas covered are safety of endoscopy in patients with liver disease,the use of standard endoscopy for the treatment of varices and the role of new endoscopic modalities such as endoscopic ultrasound,esophageal capsule,argon plasma coagulation,spyglass and endomicroscopy in the investigation and treatment of liver-related gastrointestinal and biliary pathology.It is clear that the role of the endoscopy in liver disease is well beyond that of just treating varices.As the technology in endoscopy expands,so does the role of the endoscopist in liver disease. | Christoforos Krystallis Gail S Masterton Peter C Hayes John N Plevris | 2012 | World Journal of Gastroenterology2012，18，5： | 2 |
| 9 | Prognostic value of growth-differentiation factor-15 in patients with non ST elevation acute coronary syndrome 显示文摘 | Wollert K C Kempf T Peter T Olofsson S James S Johnston N | 2007 | Circulation2007，115，： | 1 |
| 10 | Treatment of hypertension in patients 80 years of age or older显示文摘 | BECKETT N S PETER R FLETCHER A E | 2008 | N Engl J Med2008，358，18： | 1 |
| 11 | Experimental investigation of very rich laminar spherical flames under microgravity conditions显示文摘 | Jerzembeck S Matalon M Peters N | 2009 | Proceedings of the Combustion Institute2009，32，： | 1 |
| 12 | Modification of Hough Transform for circles and ellipses detection using a 2-dimensional array 显示文摘 | Raymond K K Yip Peter K S Tam Dennis N K Leung | 1992 | Pattern Recognition1992，25，9： | 1 |
| 13 | Palladium - substituted lanthanum cuprates:Application to automotive exhaust purification 显示文摘 | Guilhaume N Peter S D Primet M | 1996 | Applied Catalysis B: Environmental1996，10，： | 1 |
| 14 | Autism in Angelman syndrome:implications for autism research显示文摘 | Peters S U Beaudet A L Madduri N | | 0，，06： | 1 |
| 15 | Hyperspectral imaging: an emerging technology as a potential novel adjunct in assessing peripheral peffusion deficits and success of lower extremity revaseularizations显示文摘 | OWEN N J III MARK S PETER K | 2008 | American College of Surgeons2008，207，3： | 1 |
| 16 | Treatment of hypertensionin patients 80 years of age or older显示文摘 | Beckett N S Peters R Fletcher A E | 2008 | N Engl J Med2008，358，18： | 1 |
| 17 | New Insights into Myocardial Arrhythmogenesist Distribution of Gap-junctional Coupling in Normal, Isehaemic and Hypertrophied Human Hearts显示文摘 | Peters N S | 1996 | Clin Sci (Lond)1996，90，6： | 1 |
| 18 | Field dvices-models and their Realisation显示文摘 | RENE S PETER N CHRISTIAN D | 2002 | Industrial Technology2002，4，： | 1 |
| 19 | Tiotropiurn bromide step - up therapy for adults with uncontrolled a:th- ma显示文摘 | Peters S P Kunselman S J Icitovic N | 2010 | N Engl J Med2010，363，18： | 1 |
| 20 | Coal liquefaction, Shenhua Group, and Chinas energy security显示文摘 | Peter N Alan S Rui H C | 2004 | European Management Journal2004，22，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员